Skip to main content
94.4% of patients with sleep conditions report effective treatment: results from the UK’s largest medical cannabis survey

94.4% of patients with sleep conditions report effective treatment: results from the UK’s largest medical cannabis survey

9 min read

Sam North

Can medical cannabis help palliative care patients sleep better

Sleep problems among UK medical cannabis patients are often experienced as symptoms linked to conditions such as anxiety, depression, and chronic pain, but can also present as primary diagnoses. In the largest UK patient survey of its kind, 94.4% of respondents reported meaningful treatment effectiveness when prescribed to help with sleep concerns, with 82% noticing changes within the first week and 97.9% reporting improved quality of life.

Sleep issues are among the most commonly reported challenges for UK residents prescribed medical cannabis, but for many of our patients, they rarely exist in isolation. They tend to arrive as part of a wider picture, intertwined with conditions such as anxiety, depression, or conditions that cause chronic pain, shaping not just how patients sleep, but how they move through the day.

Key takeaways

  1. 329 respondents reported sleep-related conditions within Releaf’s wider survey of 1,669 active UK medical cannabis patients.
  2. 71.4% (235/329) reported sleep issues as a secondary symptom, while 28.6% (94/329) identified sleep as their primary diagnosis.
  3. 94.4% (304/322) described medical cannabis treatment as moderately, very, or extremely effective for sleep-related conditions.
  4. Only 0.9% (3/322) reported no perceived efficacy, showing a very small non-response group within the sleep cohort.
  5. 97.2% (308/317) noticed changes within the first month, including 82.0% (260/317) within the first week.
  6. 97.9% (322/329) reported improved quality of life, with 70.5% (232/329) describing this improvement as significant.
  7. 85.7% (282/329) reported no side effects, while reported side effects were generally managed through clinician-guided adjustments.

Contents

In November 2025, we conducted the largest survey of active UK medical cannabis patients to date, gathering responses from 1,669 individuals. Within this dataset, 329 respondents reported sleep-related conditions. Of these 329 respondents, 28.6% (94) identified sleep as a primary diagnosis, while 71.4% (235) reported it as a secondary symptom.

Taken together, the data points to a clear and difficult-to-ignore positive impact of clinically guided medical cannabis treatment for sleep issues.

Summary of key findings on medical cannabis and sleep

Area

Key finding

What it shows in real-world patient care

Treatment effectiveness

94.4% (304/322) report moderate to extremely effective outcomes

The vast majority of patients experience meaningful symptom relief when treatment is clinically guided and adjusted over time

Role of sleep in diagnosis

71.4% (235/329) report sleep as a secondary symptom

Sleep disruptions are most often driven by underlying conditions such as anxiety, depression, or chronic pain rather than treated as a standalone issue

Quality of life impact

97.9% (322/329) report improved quality of life, with 70.5% (232/329) reporting significant improvement

Improvements extend beyond sleep, affecting general quality of life, daily routine, and overall wellbeing

Speed of perceived effects

97.2% (308/317) report noticing changes within the first month, including  82.0% (260/317) within the first week and 56.1% (178/317) within 24 hours

Many patients report relatively rapid changes in symptoms, which may contribute to earlier improvements in sleep patterns

Side effects

85.7% (282/329) report no side effects

Most patients tolerate treatment well under specialist supervision, with side effects typically mild and manageable when they occur

71.4% of patients report sleep issues as a secondary symptom rather than a primary condition

While UK medical cannabis can be legally prescribed for sleep conditions in its own right, the data showed that for most patients, it formed part of a wider clinical picture. Of the 329 respondents reporting sleep-related issues, 71.4% (235) experienced them as a secondary symptom, compared to 28.6% (94) who identified sleep as their primary diagnosis.

And for many of the respondents, improvements in sleep made a big difference to their overall health and wellbeing. 

Which conditions were most commonly linked to sleep disruption?

Among patients who reported sleep as a secondary symptom, a consistent pattern emerged. Sleep disruption was most commonly associated with mental health and pain-related conditions, alongside a smaller number of neurological and mixed-condition presentations.

The most frequently reported conditions where sleep was a secondary symptom included:

94.4% of patients report meaningful effectiveness when taking UK medical cannabis for sleep conditions

Across the sleep cohort, including patients with insomnia, 304 of 322 respondents (94.4%) reported their treatment as at least moderately effective. Only 3 respondents (0.9%) reported no efficacy at all.

This pattern was seen across both primary sleep conditions and cases where sleep disruption was reported as a secondary symptom. Outcomes were generally positive, but not uniform. 

Effectiveness rating

% of patients

Number of patients

Extremely effective

37.9%

122

Very effective

40.7%

131

Moderately effective

15.8%

51

Slightly effective

4.7%

15

Not effective at all

0.9%

3

Total effective (≥ moderate)

94.4%

304/322

82.0% of patients notice effects within the first week of medical cannabis treatment

Most respondents reported relatively early changes after starting treatment. Of the 317 who answered this question, 82.0% (260) noticed effects within the first week, including 56.1% (178) who reported changes within the first day.

How quickly does medical cannabis affect sleep and symptoms?

For some patients, changes were noticed quickly, while for others, improvements developed more gradually over time. As with all prescribed treatments, individual response varied depending on the condition being treated, dosing, and ongoing clinical support.

Timeframe

% of patients

Number of patients

Within the first day

56.1%

178

Within the first week

82.0%

260

Within first month

97.2%

308

Only 2.8% of respondents (9 out of 317) reported that it took longer than one month to notice changes, although a small number of patients elsewhere in the dataset reported no perceived effectiveness.

97.9% of patients reported improved quality of life, with 85.4% reporting better day-to-day functioning

With better sleep came wider improvements in daily functioning and overall quality of life. Of the 329 respondents, 322 (97.9%) described a positive shift in their overall quality of life, including 232 (70.5%) who considered that change significant.

A similar pattern carried through into everyday life. In total, 281 respondents (85.4%) said they were better able to manage daily tasks including work and other daily responsibilities, showing that positive secondary outcomes were felt across the board

How does improved sleep contribute to overall quality of life?

Patients commonly described:

  • A steadier mood and greater emotional balance

  • Less fatigue, with more reliable energy across the day

  • A more consistent rhythm to daily life

  • Increased independence in routine activities and work

Outcome

% of patients

Number of patients

Significant improvement

70.5%

232

Slight improvement

27.4%

90

No change

1.8%

6

Worsened

0.3%

1

Total improved

97.9%

322

85.7% of patients report no side effects from UK medical cannabis treatment

As with all prescribed medical treatments, side effects form part of the wider picture of how a treatment performs in real-world settings. Medical cannabis can cause side effects, but in most cases these were mild, and were managed through discussion with clinicians who make up Releaf’s world-class clinical team, and careful adjustments to treatment over time.

For patients being treated for sleep issues, most reported no adverse effects. Of the 329 respondents, 282 (85.7%) said they did not experience any side effects whatsoever from their Releaf prescribed medical cannabis 

How does medical cannabis compare to lifestyle changes and natural alternatives for sleep support?

While medical cannabis is a ‘natural’ treatment option, it sits in a very different category to many of the other natural alternatives for sleep. As a prescribed treatment, it is assessed, monitored, and adjusted over time with full clinical oversight from a specialist doctor, rather than being self-directed.

That difference is key to point out. Combined with growing patient-reported data and clinical research, it reflects a more structured, individualised approach to managing sleep-related symptoms.

Does that mean that medical cannabis for sleep issues is more effective than supplements like melatonin and magnesium? 

Not necessarily. They tend to be used in different situations. Supplements like melatonin or magnesium are often tried first for general sleep support, while medical cannabis is usually considered when sleep issues are linked to a diagnosed condition or haven’t responded to standard approaches.

What about lifestyle changes for sleep issues? 

Lifestyle changes are a crucial piece of the puzzle when it comes to improving sleep. Think of this as the foundation, the daily habits that shape how the body winds down, how consistent sleep becomes, and how well rest is maintained over time.

This might include:

  • establishing a regular sleep schedule (7 to 8 hours a night is ideal for most adults)
  • reducing screen exposure in the evening (especially blue light)
  • managing caffeine intake (no caffeine after 2 pm is often recommended)
  • creating an environment that supports rest (temperature and light control)

How can UK patients access legal medical cannabis for sleep issues?

As the most trusted medical cannabis clinic in the UK, our care ethos is guided by specialist clinicians and supported through our Patient Dashboard, designed to manage prescriptions, follow-ups, and ongoing treatment with regular follow-up consultations to ensure that your medical cannabis treatment continues to be as effective as possible. 

To see if treatment could be suitable for you, try our medical cannabis eligibility checker. It’s free, takes less than 20 seconds, and could be the first step towards finding better health outcomes. 

Releaf - Let's rethink healthcare

It is important to seek medical advice before starting any new treatments. The patient advisors at Releaf are available to provide expert advice and support. Alternatively, click here to book a consultation with one of our specialist doctors.

Elevate your wellness with medical cannabis

Get comprehensive care, convenience, and confidence with an all-in-one treatment plan.

Am I eligible?

Further reading

The treatment option 1.77 million Brits source illegally: UK’s legal medical cannabis access gap explained

A recent paper clearly highlights the huge gap between how many adults in the UK rely on illicit cannabis to help control the symptoms of their health conditions, compared to the numberlegally prescribed. An estimated 1.77 million UK adults still self-medicate with street-bought cannabis, with only around 100,000 having a legal UK medical cannabis prescription right now, despite medical cannabis being a fully legal treatment option since November 2018.

Pride, PTSD, and plant-based approaches

Each year in June, LGBTQ+ Pride events take place around the world. These events offer an opportunity to celebrate the LGBTQ+ community, honour their contributions, and recognise the ongoing struggle for equality. But June also marks PTSD Awareness Month and, as these two important events coincide, it is important to recognise the increased rates of PTSD among LGBTQ+ individuals, understand the reasons behind this, and improve awareness of available treatment options.